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To clarify the relative contributions of psychiatric and alcohol or other drug (AOD) use disor-
ders on sexual risk for HIV infection among people with severe mental illness, we interviewed
195 psychiatric patients. In the prior 6 months the 100 (51%) sexually active patients had a
mean of 3.9 sex partners and 27.5 sex episodes; 49% had known high-risk sex partners; 34%
used AOD during sex; 28% traded sex; and 59% never used condoms. The likelihood of being
sexually active decreased with age and cognitive symptoms, increased with excited symptoms,
and was more than twice as high for African-American patients as others. The likelihood of
trading sex increased with cognitive symptoms. The likelihood of having a sexually transmitted
disease history (reported by 32% of all patients) increased with depressed/anxious symptoms,
a lifetime AOD use diagnosis (obtained for 57% of patients), and was more than twice as high
for African-American patients as others. HIV prevention interventions that address specific
psychiatric conditions and developmental and cultural issues of psychiatric patients should be
developed and tested.
KEY WORDS: HIV risk; psychiatric symptoms; severe mental illness; alcohol or other drug use disorder;
sexual behavior.
INTRODUCTION
The strong association between HIV infection
and alcohol or other drug (AOD) use is well es-
tablished. In the United States HIV remains highly
concentrated among people who inject drugs, and
unprotected sex with an infected drug injector is the
likely source of HIV infection in a large proportion
of heterosexually transmitted AIDS cases (Neal et al.,
1997). AOD use is also thought to contribute to HIV
risk by modifying sexual impulses and behavior by
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increasing sexual desire, disinhibiting sexual behav-
ior, or interfering with the practice of safer sex or all
of these (Robertson and Plant, 1988; Stall et al., 1986).
AOD use that reaches the threshold of abuse or de-
pendence is thought to increase the likelihood of trad-
ing sex to get drugs or money to buy them, and these
transactions are unlikely to be protected (Robertson
and Plant, 1988).
It is not yet known to what extent similar asso-
ciations play a part in HIV transmission among peo-
ple with severe mental illness, for whom the point
prevalence of HIV infection varies from 4.0 to 22.9%,
with the highest rates found among those with co-
morbid AOD use disorders (Cournos and McKinnon,
1997b). Rates of AOD use disorders range from 20
to 75% across psychiatric treatment settings such as
inpatient units, outpatient clinics, and homeless shel-
ters (Cournos and McKinnon, 1997a). The few studies
among these dually-diagnosed patients have exam-
ined their risk behaviors but not the relative contri-
butions of psychiatric illness and AOD use disorders
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on sexual risk taking (Hanson et al., 1992; Kim et al.,
1992).
A substantial proportion of people with severe
mental illness who do not have current AOD use
disorders nevertheless report that AOD use is a
part of their sexual experience. Among adults with
schizophrenia, 45% of sexually active inpatients and
outpatients reported using AOD during sex in the past
6 months (Cournos et al., 1994), as did 15–20% of out-
patients of all diagnoses within the past year (Kelly
et al., 1992). In these studies, rates were comparable
for men and women. Among acute-care psychiatric in-
patients, almost 40% reported alcohol use during sex
at least once during the previous 6 months (Menon
and Pomerantz, 1997), and gender differences were
found in patterns of co-occurring sex and AOD use:
among men, a significant association was observed
between using crack during sex and both inconsistent
condom use and sex with a high-risk partner; among
women, alcohol use before or during sex was signif-
icantly associated with engaging in anal sex. Trading
sex to get drugs or money to buy drugs appears to
be a common practice in certain segments of the psy-
chiatric population. Sex trading within the past year
was reported by 50% of sexually active patients with
schizophrenia (Cournos et al., 1994), 47% of sexually
active homeless men receiving psychiatric treatment
in a shelter (Susser and Valencia, 1993), and 13% of
outpatients with severe mental illness (Kelly et al.,
1992). Men and women in this population appear to
differ in their trading activities, men trading drugs
for sex, and women trading sex for drugs (Kalichman
et al., 1994).
Although little is known about the risk pro-
files of patients’ sexual partners, some patients report
having partners with AOD-related risk for HIV in-
fection. Sexual intercourse with a partner who was
known to inject drugs was reported by 3% of psychi-
atric outpatients for the previous month (Kelly et al.,
1992), 8% of sexually active inpatients and outpa-
tients with schizophrenia for the previous 6 months
(Cournos et al., 1994), 12% of homeless men with psy-
chiatric disorders for the previous 6 months (Susser
and Valencia, 1993), and 7–13% of psychiatric outpa-
tients for the previous year (Kalichman et al., 1995).
Lifetime prevalence of sex with a drug injector was
6% in one study of outpatients (Hellerstein and
Prager, 1992), and 8% of male and 9% of female
outpatients in another study (Kalichman et al., 1994).
Drug-injecting sexual partners may be more typical of
women, particularly those with bipolar disorder, than
of men, although the evidence for this is inconsistent
(Kalichman et al., 1994; Volavka et al., 1991). How-
ever, because many patients have sex with partners
they do not know well (Kelly et al., 1992), the specific
risks of partners often are not determined.
To date no study has examined the extent to
which psychiatric symptoms, the defining character-
istic of this population, and AOD use disorders both
contribute to unsafe sexual activity. In a previous
study (McKinnon et al., 1996), we found that ex-
cited symptoms, positive symptoms, and a diagnosis
of schizophrenia were predictive of specific types of
sexual risk-taking; however, we did not examine the
role of comorbid AOD use disorders in these sex-
ual risk behaviors, and recent reports (McKinnon and
Cournos, 1998) show that noninjected drug use is asso-
ciated with HIV infection among people with severe
mental illness, suggesting a link with sexual behavior.
Prescribed psychotropic drugs also may affect sexual
behavior; many have side effects that impinge on sex-
ual functioning (Clayton and Shen, 1998). Previous
studies of sexual risk in the psychiatric population
have not considered such side effects in sexual risk
taking.
In the present study we sought to clarify the rela-
tive contributions of psychiatric and AOD use disor-
ders on sexual risk for HIV infection among psychi-
atric inpatients and outpatients. We wanted to learn
whether specific psychiatric symptom clusters, level
of functioning, sexual side effects of psychiatric med-
ication, or comorbid AOD use disorders predicted
seven sexual behaviors in the prior 6 months: hav-
ing sex with a partner, having multiple sex episodes,
having multiple sex partners, having a high-risk sex
partner, using AOD during sex, trading sex, or us-
ing condoms inconsistently. We also wanted to learn
whether any of these factors increased the likelihood
of having had a sexually transmitted disease (STD) at
any time in the past as a proxy for unprotected sexual
behavior. We expected the likelihood of sexual risk
behavior and the likelihood of having an STD history
to increase in the presence of an AOD use disorder,
more severe psychopathology, and a lower level of
functioning, and to decrease with sexual side effects
of psychiatric medications.
METHODS
We conducted face-to-face interviews with 200
inpatients and outpatients who were receiving psy-
chiatric treatment in state-operated public mental
health programs in New York City. Interviews were
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completed in the early 1990s, the same period dur-
ing which New York City seroprevalence data were
collected which show an association between HIV
seropositivity and comorbid drug abuse among psy-
chiatric patients (McKinnon and Cournos, 1998). Peo-
ple with a primary AOD use diagnosis or central
nervous system dysfunction due to a general medical
condition were excluded by administrative mandate
from admission to the treatment sites.
We asked all patients between the ages of 18 and
59 years who were evaluated by their primary clini-
cian as being capable of consenting to research and of
completing an interview primarily in English to partic-
ipate in the study. After fully explaining all study pro-
cedures, we obtained written informed consent from
patients; those who completed the assessment battery
were paid $15 for their participation.
All interviews were conducted in English by
trained bilingual researchers who translated as neces-
sary when a patient’s primary language was Spanish.
We obtained an Axis I psychiatric diagnosis including
lifetime substance abuse or dependence disorders us-
ing the Structured Clinical Interview for DSM-III-R
(SCID; Spitzer et al., 1990). The SCID does not assess
route of drug administration. We also used the SCID
to obtain a Global Assessment of Functioning (GAF)
score (range: 0 D persistent danger to self or others
to 90 D absent or minimal symptoms). The interview
battery also consisted of the Positive and Negative
Syndrome Scale (PANSS) (Kay et al., 1990), which
measures severity of 30 psychiatric symptoms (each
on a scale from 1 D absent to 7 D extreme); the Sex-
ual Risk Behavior Assessment Schedule (SERBAS;
Meyer-Bahlburg et al., 1990), an extensive interview
with demonstrated reliability among psychiatric in-
patients and outpatients (McKinnon et al., 1993); an
interview which assesses sexual side effects of psychi-
atric medications (Horwath et al., 1990a); and a sex-
ually transmitted disease interview (Horwath et al.,
1990b) that elicits both diagnostic and symptom his-
tories for the past 6 months and lifetime (excluding
the past 6 months).
We sought to develop a prediction model using
multiple logistic regression analysis. The categorical
independent variable “ethnicity” was dichotomized
as African-American versus non-African-American
because a previous study at the same treatment sites
(Cournos et al., 1991) found disproportionately ele-
vated HIV infection rates among African-American
patients. Psychiatric symptoms were scored using
the reliable and valid five-factor classification (Bell
et al., 1994; Lindenmayer et al., 1994; Lindenmayer
et al., 1995) of the PANSS: cognitive symptoms
(conceptual disorganization, difficulty with abstract
thinking, disorientation, poor attention, mannerisms/
posturing; score range: 5–35); positive symptoms
(delusions, unusual thought content, grandiosity, sus-
piciousness/persecution; range: 4–28); negative symp-
toms (emotional withdrawal, passive/apathetic with-
drawal, lack of spontaneous conversation, poor
rapport, blunted affect, active social avoidance;
range: 6–42); excited symptoms (excitement, poor
impulse control, hostility, tension; range: 4–28); or
depressed/anxious symptoms (anxiety, guilt feelings,
depression, somatic concerns, preoccupation; range:
5–35).
The dependent variables sexual activity with a
partner, high-risk sex partners, AOD use during sex,
sex trading, condom use, and having an STD history
were dichotomized as any versus none; number of
sex episodes and number of sex partners were not
transformed. Chi square and Pearson correlation tests
were performed; independent variables significantly
associated with dependent variables were included in
the regression equation for that dependent variable
(Hosmer and Lemeshow, 1989). Adjusted odd ratios
(ORs) and 95% confidence intervals (CIs) were cal-
culated to estimate relative risk of each of these be-
haviors (Fleiss, 1981), controlling for the effects of all




We obtained written informed consent from 203
(76.9%) of 264 eligible patients. Of these, three pa-
tients dropped out before any interview, leaving 200
completed interviews. Interviewers rated the sexual
risk behavior responses of four patients as unreliable
because of severe cognitive deficits, impaired mem-
ory, or borderline IQ, and excluded those of one other
patient whose primary language was neither English
nor Spanish who did not understand the questions. We
excluded from statistical analysis all data from these
five patients, resulting in a total sample of 195 patients.
Following institutional review board confiden-
tiality protocols, we collected limited demographic
and clinical data from the medical records of all pa-
tients eligible for the study to compare participants
and nonparticipants. Patients who did not consent to
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participate in the study were not significantly different
from participants in gender or number of previous
psychiatric hospitalizations. The mean § SD age of
nonparticipants was 39:72§ 11:16 years, which was
significantly older than that of participants (36.38 §
9.05; t D 2:15, df D 95:25, p D :03).
Participant Characteristics
Gender and ethnic distributions were represen-
tative of the units from which patients were recruited:
men comprised 64% of the sample, and approxi-
mately one-third of each were African-American,
Latino, and white/other.
Psychiatric Characteristics of Participants
More than one-third (38.9%) of participants
were outpatients, 33.8% were from a unit that pre-
pares patients for discharge into the community, and
27.1% were from inpatient units. No significant differ-
ences in number of previous psychiatric hospitaliza-
tions, GAF scores, or psychiatric diagnosis were found
between these patient groups which we combined.
The most prevalent primary SCID diagnosis was
schizophrenia (49.4%), followed by other psychoses
(29.2%), bipolar disorder (11.8%), major depression
(7.3%), and other Axis I disorders (2.3%). Most
patients (77.0%) had multiple previous psychiatric
hospitalizations; only 15 (7.5%) had none. The me-
dian GAF score was 40 (range: 1–70), indicating sub-
stantial impairment in reality testing, communication,
thinking, or mood. A lifetime AOD use disorder was
obtained for 56.8% of the sample.
Median PANSS scores for symptom clusters were
lowest for positive (6, range: 3–21), excited (5, range:
4–15), and depressed/anxious (7, range: 4–20) symp-
toms and higher for cognitive (11, range: 4–23) and
negative (14, range: 6–29). These scores are consistent
with schizophrenia-spectrum diagnoses, which were
predominant, and chronic psychiatric illness currently
stabilized.
Sexual Risk Characteristics of Participants
The 100 patients (51.3% of the sample) who
were sexually active with a partner in the previous
6 months had a mean § SD of 3:9§ 1:47 sex part-
ners and 27:5§ 5:19 sex episodes; 48.5% had known
high-risk sex partners; 33.7% used AOD during sex;
28.3% traded sex; and 58.5% never used condoms. A
majority (67.2%) of all patients reported a history of
sexual side effects of psychiatric medications and 32%
reported a history of STDs.
Factors Associated With Sexual Risk Behavior
Demographic Characteristics
Age was significantly negatively correlated with
being sexually active (r D ¡:273, p D :000): Gender
was significantly associated with having a high-risk sex
partner (´2 D 6:30, df D 1, p D :01), with 12 (66.7%)
of 28 women reporting this risk compared with six
(33.3%) of 53 men. African-American ethnicity was
significantly associated with being sexually active
(´2 D 4.07, df D 1, p D .04) and with having an STD
history (´2 D 4.18, df D 1, p D .04).
Psychiatric Characteristics
Cognitive symptoms were significantly nega-
tively correlated with being sexually active (r D
¡:235, p D :001) and positively correlated with trad-
ing sex (r D :302, p D :003):Negative symptoms were
significantly negatively correlated with being sexually
active (r D ¡.196, p D .008) and positively corre-
lated with number of sex partners (r D :171, p D :021)
and trading sex (r D :225, p D :029): Excited symp-
toms were significantly positively correlated with be-
ing sexually active (r D :185, p D :012) and number of
sex episodes (r D :200, p D :007):Depressed/anxious
symptoms were significantly positively correlated
with an STD history (r D :156, p D :04): A lifetime
AOD use disorder was significantly associated with an
STD history (´2 D 6:62, df D 1, p D :01): No associ-
ation was found between psychiatric diagnosis, GAF
score, positive symptoms, or self-reported sexual side
effects of psychotropic medications and any of the risk
behaviors we measured.
Condom use was not associated with any of the
demographic or psychiatric factors we examined in
this study.
Predictors of Sexual Risk Behavior
To estimate the relative risk of a specific HIV-
related sexual behavior, we controlled simultane-
ously for the effects of all associated factors to ob-
tain adjusted odd ratios which are shown in Table I.
Logistic models are presented only for the three
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Table I. Predictors of HIV Risk Activity Among 195 Psychiatric Patients
Sexually active with a partner Sex tradinga STD history
Factor Adjusted OR (95% CI) p Adjusted OR (95% CI) p Adjusted OR (95% CI) p
Ageb 1.06 (1.02–1.10) .004 — —
Genderc 1.35 (0.65–1.03) .42 1.11 (0.37–3.36) .84 1.48 (0.61–3.64) .39
Ethnicityd 2.36 (1.18–4.73) .02 — 2.61 (1.14–5.98) .02
Cognitive symptoms 1.10 (1.01–1.20)e .02 1.18 (1.03–1.35) f .02 —
Negative symptoms 1.04 (0.97–1.10)e .26 1.29 (0.12–13.49) f .83 —
Excited symptoms 1.18 (1.03–1.34) f .02 — —
Depressed/Anxious symptoms — — 1.17 (1.04–1.31) f .007
AOD use disorder — — 3.21 (1.30–7.92) .01
aSexually active patients only.
bYounger age increased the likelihood of being sexually active.
cFemale patients were more likely than male patients to have cognitive and depressed/anxious symptoms and a lifetime AOD use disorder
whereas male patients were more likely than female patients to have negative symptoms.
dAfrican-American patients were more likely than others to be sexually active and to have an STD history.
eLess-severe symptoms increased the likelihood of this behavior.
f More-severe symptoms increased the likelihood of this behavior.
dependent variables for which significant predictors
were found. Because female gender was significantly
associated with cognitive symptoms (r D ¡:352, p D
:000), negative symptoms (r D ¡:285, p D :000), de-
pressed/anxious symptoms (r D :147, p D :047), and
men were significantly more likely than women to
have a lifetime AOD use disorder (´2 D 15:13, df D
1, p D :000), we included gender in all regression
equations.
Sexual Activity With a Partner
When the simultaneous contribution of age, gen-
der, ethnicity, and cognitive, negative, and excited
symptoms was considered, age, cognitive symptoms,
and excited symptoms increased the likelihood of be-
ing sexually active with a partner by a factor of one
and African-American ethnicity increased the likeli-
hood by more than twofold. Neither female gender
nor negative symptoms significantly increase the like-
lihood of having sex with a partner.
Sex Trading
After simultaneously controlling for the inde-
pendent contributions of gender and cognitive and
negative symptoms, only cognitive symptoms signif-
icantly increased the likelihood of trading sex by a
factor of one.
STD History
After controlling for the simultaneous contribut-
ion of gender, ethnicity, depressed/anxious symptoms,
and a lifetime AOD use disorder, only gender did not
independently increase the likelihood of a reported
STD history; an AOD use disorder increased this like-
lihood by more than threefold; ethnicity by nearly
threefold; and depressed/anxious symptoms by a fac-
tor of one.
DISCUSSION
We sought to delineate the relative contributions
of comorbid psychiatric and AOD use disorders to
sexual behaviors associated with HIV infection in a
group of people in treatment for severe mental illness.
Our findings confirmed several hypotheses about the
relationship between specific psychiatric symptoms,
AOD use disorders, and HIV risk behaviors in this
population.
Although being sexually active is not risky per se,
we present findings about factors associated with
being sexually active because sexual behavior is a
necessary condition for sexual risk behavior. Cogni-
tive symptoms appear to have a differential impact
upon sexual risk: lower-severity symptoms increased
the likelihood of being sexually active, while higher-
severity symptoms increased the likelihood of trading
sex. One possible explanation for these findings is that
more-severe cognitive impairment may reduce the de-
sire or capacity for sexual activity but also interfere
with the ability to manage limited resources to the ex-
tent that bartering sex for money or a place to stay,
also known as “survival sex,” suggests itself. It also
may be that cognitive impairment increases vulnera-
bility to subtle or overt coercion. Although cognitive
symptoms may be more severe among patients with
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acute drug abuse or dependence, in our sample sever-
ity of cognitive symptoms was not associated with hav-
ing a lifetime AOD use disorder.
Higher-severity excited symptoms increased the
likelihood of being sexually active and were posi-
tively correlated with the total number of sex episodes
patients engaged in. This association between ex-
cited symptoms and the number of sexual episodes
may support clinical assumptions described in the
literature implicating poor impulse control in HIV
risk taking, although we cannot say whether these
contacts took place in the context of monogamous
relationships or with partners with HIV risk or infec-
tion. If this finding is replicated in future studies that
take such contextual factors into account, interven-
tions designed to help patients to reduce impulsivity
could be implemented as a harm-reduction strategy.
The depressed/anxious symptom cluster also
contributed to increased HIV risk: higher-severity
symptoms increased the likelihood of having an STD
history. In future studies it will be important to learn
the sequence in which these conditions occur and
whether treating one reduces the likelihood of the
other. It is possible that depression affects self-efficacy
to negotiate or practice safer sex or both. This hypoth-
esis would be important to test.
Contrary to previous findings (McKinnon et al.,
1996), neither positive symptoms nor psychiatric di-
agnosis predicted any sexual risk for HIV that we
measured. Nor did we find any association between
a patient’s overall level of functioning (measured by
the GAF) or self-reported sexual side effects of pa-
tients’ prescribed psychiatric medications and HIV
risk. Carefully designed studies are needed to un-
derstand how particular psychiatric and medication-
induced conditions affect sexual functioning and risk
taking.
A lifetime history of AOD abuse or depen-
dence increased by threefold the likelihood of hav-
ing an STD history. This finding may explain, in
part, why HIV infection rates are high among peo-
ple with comorbid AOD use disorders and psychi-
atric illness who do not have drug injection histo-
ries. Even patients without an AOD use disorder
may use alcohol or other drugs in ways that increase
their risk for exposure to HIV from sexual contacts
(McKinnon and Cournos, 1998). A substantial pro-
portion of sexually active patients traded sex for
drugs, among other goods. Contrary to expectations,
AOD use disorders did not predict having high-risk
sex partners.
Several demographic factors predicted sexual
HIV risk in our sample. Women were more likely
by far than men to have sex partners with known
HIV risks, predominantly AOD use. Younger age in-
creased the likelihood of being sexually active. Both
being sexually active and having an STD history were
more than twice as likely among African-American
patients than those of other groups.
In this study, we established an association be-
tween lifetime AOD use disorders and a history of
sexually transmitted disease. It has been argued that
a propensity toward risk taking or sensation seeking
may account for the coincidence of sexual and drug
use risk behaviors (Kalichman et al., 1996; Leigh and
Stall, 1993). This perspective, although valid, may be
too narrowly focused on the individual and may not
explain our findings among people with severe men-
tal illness for whom environmental factors, including
transient living conditions and the existence of sexual
and drug-use networks in urban psychiatric treatment
settings, may make AIDS prevention or the avoid-
ance of risk behaviors a low priority or difficult to
initiate. Research is needed on the impact of specific
aspects of psychiatric illness and AOD use patterns
on sexual risk behavior (McKinnon et al., 1997) in or-
der to understand whether mental illness directly in-
creases HIV risk or whether sequelae of mental illness
(e.g., use of AOD to alleviate psychiatric symptoms)
or associated conditions (e.g., poverty due to unem-
ployment, residence in poor, HIV-endemic neighbor-
hoods) contribute to the high infection rates seen in
this disadvantaged population.
STUDY LIMITATIONS
Patients we interviewed were receiving psychi-
atric care in urban, public treatment settings, primar-
ily as outpatients being prepared to return to the
community. Although most patients were interviewed
during a period of compromised reality testing or
other functional impairment, whether they were in-
patients or outpatients they were otherwise psychi-
atrically stabilized and capable of giving informed
consent, which may account for the lack of significant
differences between patient groups in GAF scores.
Most had chronic psychiatric illness, as evidenced by
their symptom profile (more-severe negative and cog-
nitive symptoms) and numerous previous psychiatric
hospitalizations, most commonly schizophrenia. Fu-
ture studies that are designed to examine the role of
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bipolar disorder in HIV risk taking will need to se-
lect samples containing a larger proportion of patients
with this diagnosis than we had (12%); excited and de-
pressed/anxious symptoms, which predicted specific
sexual risks in our sample, are important components
of bipolar disorder and deserve further examination.
Psychiatric patients in other treatment settings and
people with mental illness who are more acutely ill
or not receiving treatment may differ clinically and
in their rates and types of sexual risk behavior. The
significantly younger mean age of participants in our
study compared with non-participants may have led
us to overestimate rates of sexual behaviors since sex-
ual activity is more prevalent among the young. Nev-
ertheless, patients in this study may be typical of many
psychiatric patients who are sexually active, and our
findings are in line with previous sexual risk behavior
prevalence studies which show similarly high rates of
being sexually active with a partner, having multiple
sex partners and occasions, having sex partners with
known HIV risks, using AOD during sex, trading sex,
and using condoms inconsistently (Carey et al., 1997).
Sexual and drug use behaviors may change over time,
and our findings reflect behavior patterns reported by
patients in the early 1990s which may have undergone
important changes in response to media campaigns or
even targeted interventions, among other factors. The
strength of the data we collected is that they are con-
temporaneous with the only available seroprevalence
data obtained to date from people with severe men-
tal illness and, as such, may suggest relationships to
examine in future research. Additional studies, espe-
cially longitudinal examinations of psychiatric condi-
tions and HIV risk behaviors linked to serostatus in
this population, are needed.
CONCLUSIONS
People with severe mental illness need HIV-
prevention interventions to reduce their sexual risk
for acquiring or transmitting the virus. The treatment
of a psychiatric patient’s AOD use disorder in and
of itself may be a powerful HIV prevention strat-
egy. However, it would be inappropriate to focus on
those with a defined dual diagnosis of mental illness
and AOD use disorder since these comorbidities of-
ten go undetected (Cournos and McKinnon, 1997b)
and since use of AOD can affect risk taking even in
the absence of an AOD use disorder. Prevention in-
terventions that teach all patients concrete skills to
manage psychiatric states that trigger or sustain HIV
risk behaviors may reduce the impact of the epidemic
among them. Such interventions that are develop-
mentally and culturally appropriate to patients should
be developed and tested.
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